Cardlytics, Inc.
For the period ended Dec 31, 2025. Filed Mar 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 4, 2026
CDLX$1.63-10.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Deficit) Equity
Year Ended December 31, 2025:
| AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · Total | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares · Amount | ||||||
| Balance – December 31, 2024 | 51,257 | $10 | $1,366,958 | $3,601 | $(1,300,576) | $69,993 |
| Stock-based compensation | — | — | 31,945 | — | — | 31,945 |
| Issuance of restricted stock | 2,833 | — | — | — | — | — |
| Issuance of common stock pursuant to the 2018 ESPP (as defined below) | 424 | — | 639 | — | — | 639 |
| Other comprehensive loss | — | — | — | (5,597) | — | (5,597) |
| Net loss | — | — | — | — | (103,488) | (103,488) |
| Balance – December 31, 2025 | 54,514 | $10 | $1,399,542 | $(1,996) | $(1,404,064) | $(6,508) |
Year Ended December 31, 2024:
| AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · Total | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares · Amount | ||||||
| Balance – December 31, 2023 | 39,728 | $9 | $1,243,594 | $2,467 | $(1,111,272) | $134,798 |
| Exercise of common stock options | 6 | — | 15 | — | — | 15 |
| Stock-based compensation | — | — | 45,370 | — | — | 45,370 |
| Issuance of restricted stock | 3,503 | 1 | — | — | — | 1 |
| Issuance of common stock, net of issuance costs | 3,592 | — | 27,451 | — | — | 27,451 |
| Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below) | 3,908 | — | 48,151 | — | — | 48,151 |
| Issuance of common stock pursuant to the 2018 ESPP (as defined below) | 520 | — | 2,262 | — | — | 2,262 |
| Termination of capped calls related to 2020 Convertible Senior Notes | — | — | 115 | — | — | 115 |
| Other comprehensive income | — | — | — | 1,134 | — | 1,134 |
| Net loss | — | — | — | — | (189,304) | (189,304) |
| Balance – December 31, 2024 | 51,257 | $10 | $1,366,958 | $3,601 | $(1,300,576) | $69,993 |
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY
Year Ended December 31, 2023:
| AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · Total | |||||||
|---|---|---|---|---|---|---|---|
| Common Stock | |||||||
| Shares · Amount | |||||||
| Balance – December 31, 2022 | 33,477 | $9 | $1,182,568 | $5,598 | $(976,570) | $211,605 | |
| Exercise of common stock options | 10 | — | 54 | — | — | 54 | |
| Stock-based compensation | — | — | 43,466 | — | — | 43,466 | |
| Issuance of restricted stock | 2,930 | — | — | — | — | — | |
| Issuance of common stock | 2,755 | — | 15,171 | 15,171 | |||
| Issuance of common stock pursuant to the 2018 ESPP (as defined below) | 556 | — | 2,335 | — | — | 2,335 | |
| Other comprehensive loss | — | — | — | (3,131) | — | (3,131) | |
| Net loss | — | — | — | — | (134,702) | (134,702) | |
| Balance – December 31, 2023 | 39,728 | $9 | $1,243,594 | $2,467 | $(1,111,272) | $134,798 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.